Erratum: Insulinoma: analysis of prevalence and incidence in the world (Endocrine surgery. 2023;17(2):4-10. doi: https://doi.org/10.14341/serg12805)

M. Yu. Yukina; A. R. Elfimova; E. A. Troshina; G. A. Melnichenko; N. G. Mokrysheva

doi:10.14341/serg13019

Erratum: Insulinoma: analysis of prevalence and incidence in the world (Endocrine surgery. 2023;17(2):4-10. doi: https://doi.org/10.14341/serg12805)

M. Yu. Yukina, A. R. Elfimova, E. A. Troshina, G. A. Melnichenko, N. G. Mokrysheva

https://doi.org/10.14341/serg13019

Full Text:

PDF (Rus)

Generate QR code

Abstract

An erratum on «Insulinoma: analysis of prevalence and incidence in the world» by Marina Yu. Yukina, Alina R. Elfimova, Ekaterina A. Troshina, Galina A. Melnichenko, Natalia G. Mokrysheva (2023). Endocrine surgery. 17(2):4-10. doi: https://doi.org/10.14341/serg12805.

An error was made in the annotations in Russian and English (section «Results»), table 1, in paragraph 1 on page 7, in paragraph 5 on page 8 — the following prevalence of insulinoma in the Russian Federation is indicated: 11.9 per 1 million population. The correct prevalence of insulinoma in the Russian Federation is 11.5 per 1 million population. The editorial board apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article has been updated.